- Home
- VTYX vs AIRS Comparison
VTYX vs AIRS Comparison
Compare VTYX & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- AIRS
- Stock Information
- Founded
- VTYX 2018
- AIRS 2012
- Country
- VTYX United States
- AIRS United States
- Employees
- VTYX N/A
- AIRS N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- AIRS Medical/Nursing Services
- Sector
- VTYX Health Care
- AIRS Health Care
- Exchange
- VTYX Nasdaq
- AIRS Nasdaq
- Market Cap
- VTYX 154.9M
- AIRS 166.3M
- IPO Year
- VTYX 2021
- AIRS 2021
- Fundamental
- Price
- VTYX $2.30
- AIRS $6.20
- Analyst Decision
- VTYX Buy
- AIRS Hold
- Analyst Count
- VTYX 2
- AIRS 3
- Target Price
- VTYX $9.00
- AIRS $3.75
- AVG Volume (30 Days)
- VTYX 441.6K
- AIRS 515.3K
- Earning Date
- VTYX 11-06-2025
- AIRS 11-07-2025
- Dividend Yield
- VTYX N/A
- AIRS N/A
- EPS Growth
- VTYX N/A
- AIRS N/A
- EPS
- VTYX N/A
- AIRS N/A
- Revenue
- VTYX N/A
- AIRS $165,109,000.00
- Revenue This Year
- VTYX N/A
- AIRS N/A
- Revenue Next Year
- VTYX N/A
- AIRS $5.14
- P/E Ratio
- VTYX N/A
- AIRS N/A
- Revenue Growth
- VTYX N/A
- AIRS N/A
- 52 Week Low
- VTYX $0.78
- AIRS $1.53
- 52 Week High
- VTYX $3.39
- AIRS $9.20
- Technical
- Relative Strength Index (RSI)
- VTYX 39.52
- AIRS 50.13
- Support Level
- VTYX $2.31
- AIRS $5.73
- Resistance Level
- VTYX $2.54
- AIRS $6.39
- Average True Range (ATR)
- VTYX 0.14
- AIRS 0.36
- MACD
- VTYX -0.02
- AIRS -0.04
- Stochastic Oscillator
- VTYX 0.00
- AIRS 40.17
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.